Fauchier Laurent, Marie Olivier, Casset-Senon Danielle, Babuty Dominique, Cosnay Pierre, Fauchier Jean Paul
Service de Cardiologie B., Centre Hospitalier Universitaire Trousseau, 37044 Tours, France.
Pacing Clin Electrophysiol. 2003 Jan;26(1P2):352-6. doi: 10.1046/j.1460-9592.2003.00048.x.
Biventricular pacing is a new form of treatment for patients with dilated cardiomyopathy and ventricular dyssynchrony. Limited information is available regarding the relationship between ventricular dyssynchrony and risk markers of ventricular arrhythmias in idiopathic dilated cardiomyopathy (IDC). In 103 patients with IDC, Fourier phase analysis of both ventricles was performed from equilibrium radionuclide angiography (ERNA). The difference between the mean phase of the LV and RV was a measure of interventricular dyssynchrony, and the standard deviations of the mean phases in each ventricle measured intraventricular dyssynchrony. There were no significant differences in inter- and intraventricular dyssynchrony between patients with versus without histories of sustained VT or VF, nonsustained VT, abnormal signal-averaged ECG, or induced sustained monomorphic VT. Dyssynchrony was not related to decreased heart rate variability (HRV). LV and interventricular dyssynchrony were weakly related to QT duration and QT dispersion. During a follow-up of 27 +/- 23 months, 21 patients had major adverse cardiac events (MACE), including 7 cardiac deaths, 11 progression of heart failure leading to cardiac transplantation, and 3 sustained VT/VF. The only independent predictors of MACE were an increased standard deviation of LV mean phase (P = 0.003), a decreased HRV (standard deviation of normal-to-normal intervals, P = 0.004), and histories of previous VT/VF (P = 0.03) or nonsustained VT (P = 0.04). In conclusion, left intraventricular dyssynchrony evaluated with ERNA was an independent predictor of MACE in IDC and was not related to usual risk markers of ventricular arrhythmias. This may have implications for resynchronization therapy and/or the use of implantable cardioverter defibrillators in IDC.
双心室起搏是治疗扩张型心肌病和心室不同步患者的一种新方法。关于特发性扩张型心肌病(IDC)中心室不同步与室性心律失常风险标志物之间的关系,现有信息有限。在103例IDC患者中,通过平衡放射性核素血管造影(ERNA)对双心室进行傅里叶相位分析。左心室(LV)和右心室(RV)平均相位之间的差异是心室间不同步的一种度量,每个心室内平均相位的标准差测量心室内心不同步。有或无持续性室性心动过速(VT)或心室颤动(VF)病史、非持续性VT、异常信号平均心电图或诱发性持续性单形性VT的患者,其心室间和心室内不同步无显著差异。不同步与心率变异性(HRV)降低无关。LV和心室间不同步与QT间期和QT离散度弱相关。在27±23个月的随访期间,21例患者发生了主要不良心脏事件(MACE),包括7例心源性死亡、11例心力衰竭进展导致心脏移植以及3例持续性VT/VF。MACE的唯一独立预测因素是LV平均相位标准差增加(P = 0.003)、HRV降低(正常RR间期标准差,P = 0.004)以及既往VT/VF病史(P = 0.03)或非持续性VT病史(P = 0.04)。总之,通过ERNA评估的左心室内不同步是IDC中MACE的独立预测因素,且与室性心律失常的常见风险标志物无关。这可能对IDC中的再同步治疗和/或植入式心脏复律除颤器的使用具有启示意义。